Cargando…

Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic

The Japanese Respiratory Society (JRS) has recommended spirometry for the diagnosis of respiratory diseases. It is indispensable for the confirmation of airflow obstruction by spirometry in chronic obstructive pulmonary disease (COPD) diagnosis. However, the coronavirus disease 2019 (COVID-19) pande...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Yoko, Muro, Shigeo, Yokoyama, Akihito, Hashimoto, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023148/
https://www.ncbi.nlm.nih.gov/pubmed/33893068
http://dx.doi.org/10.1016/j.resinv.2021.03.004
_version_ 1783675072991461376
author Shibata, Yoko
Muro, Shigeo
Yokoyama, Akihito
Hashimoto, Shu
author_facet Shibata, Yoko
Muro, Shigeo
Yokoyama, Akihito
Hashimoto, Shu
author_sort Shibata, Yoko
collection PubMed
description The Japanese Respiratory Society (JRS) has recommended spirometry for the diagnosis of respiratory diseases. It is indispensable for the confirmation of airflow obstruction by spirometry in chronic obstructive pulmonary disease (COPD) diagnosis. However, the coronavirus disease 2019 (COVID-19) pandemic has made it difficult for many clinics to perform spirometry as it may lead to possible aerosol infections. Thus, the diagnosis of COPD, especially in the early stage, has become difficult. To overcome this situation, JRS issued a “Flowchart of Working Diagnosis and Management of COPD during the COVID-19 Pandemic”. This flowchart may help physicians provisionally diagnose COPD patients without performing spirometry, offering them appropriate intervention even in epidemic and pandemic situations.
format Online
Article
Text
id pubmed-8023148
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Respiratory Society. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-80231482021-04-06 Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic Shibata, Yoko Muro, Shigeo Yokoyama, Akihito Hashimoto, Shu Respir Investig Statement The Japanese Respiratory Society (JRS) has recommended spirometry for the diagnosis of respiratory diseases. It is indispensable for the confirmation of airflow obstruction by spirometry in chronic obstructive pulmonary disease (COPD) diagnosis. However, the coronavirus disease 2019 (COVID-19) pandemic has made it difficult for many clinics to perform spirometry as it may lead to possible aerosol infections. Thus, the diagnosis of COPD, especially in the early stage, has become difficult. To overcome this situation, JRS issued a “Flowchart of Working Diagnosis and Management of COPD during the COVID-19 Pandemic”. This flowchart may help physicians provisionally diagnose COPD patients without performing spirometry, offering them appropriate intervention even in epidemic and pandemic situations. The Japanese Respiratory Society. Published by Elsevier B.V. 2021-07 2021-04-06 /pmc/articles/PMC8023148/ /pubmed/33893068 http://dx.doi.org/10.1016/j.resinv.2021.03.004 Text en © 2021 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Statement
Shibata, Yoko
Muro, Shigeo
Yokoyama, Akihito
Hashimoto, Shu
Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic
title Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic
title_full Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic
title_fullStr Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic
title_full_unstemmed Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic
title_short Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic
title_sort statement from the japanese respiratory society: working diagnosis and initial management of copd during the covid-19 pandemic
topic Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023148/
https://www.ncbi.nlm.nih.gov/pubmed/33893068
http://dx.doi.org/10.1016/j.resinv.2021.03.004
work_keys_str_mv AT shibatayoko statementfromthejapaneserespiratorysocietyworkingdiagnosisandinitialmanagementofcopdduringthecovid19pandemic
AT muroshigeo statementfromthejapaneserespiratorysocietyworkingdiagnosisandinitialmanagementofcopdduringthecovid19pandemic
AT yokoyamaakihito statementfromthejapaneserespiratorysocietyworkingdiagnosisandinitialmanagementofcopdduringthecovid19pandemic
AT hashimotoshu statementfromthejapaneserespiratorysocietyworkingdiagnosisandinitialmanagementofcopdduringthecovid19pandemic